World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
62404
World Ranking
5246
National Ranking
518

Overview

David C. Wheeler is affiliated with University College London in the United Kingdom. Their research focuses primarily on medicine, with a notable concentration in the subfields of endocrinology, diabetes and metabolism, nephrology, surgery, hematology, and pulmonary and respiratory medicine.

The scientist's work covers multiple topics related to diabetes and kidney disease. These topics include:

  • Diabetes Treatment and Management
  • Chronic Kidney Disease and Diabetes
  • Pancreatic function and diabetes
  • Dialysis and Renal Disease Management
  • Diabetes Management and Research
  • Potassium and Related Disorders
  • Erythropoietin and Anemia Treatment

Their scholarly output includes various papers published in well-known academic journals. Some recent publications are:

  • "Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial," 2020, The Lancet Diabetes & Endocrinology
  • "A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy," 2021, Kidney International

In addition to these, coauthors with whom Wheeler has frequently collaborated include:

  • Hiddo J.L. Heerspink
  • John J.V. McMurray
  • Glenn M. Chertow
  • Vlado Perkovic
  • Peter Rossing

Their research is regularly published in several specific venues, which are among the prominent publications in their field. These include:

  • Journal of the American Society of Nephrology
  • Nephrology Dialysis Transplantation
  • Kidney International Reports
  • Clinical Journal of the American Society of Nephrology
  • Diabetes

David C. Wheeler's investigations contribute substantially to the understanding and management of diabetes and kidney-related conditions, particularly focusing on treatment strategies and patient outcomes.

Best Publications

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    Francesco Cosentino;Peter J Grant;Victor Aboyans;Clifford J Bailey

  • Dapagliflozin in Patients with Chronic Kidney Disease

    Hiddo J.L. Heerspink;Bergur V. Stefánsson;Ricardo Correa-Rotter;Glenn M. Chertow

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

    A.S. Levey;R. Atkins;J. Coresh;E.P. Cohen

  • Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    Adeera Levin;Marcello Tonelli;Joseph Bonventre;Josef Coresh

  • Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

    Evolve Trial Investigators;Chertow Gm;Block Ga;Correa-Rotter R

  • New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003

    Jaime Davidson;Alan Wilkinson;Jacques Dantal;Francesco Dotta

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Premature cardiovascular disease in chronic renal failure.

    Colin Baigent;Kate Burbury;David Wheeler

  • KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword

    DC Wheeler;WC Winkelmayer

  • SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

    Brendon L Neuen;Tamara Young;Hiddo J L Heerspink;Hiddo J L Heerspink;Bruce Neal;Bruce Neal;Bruce Neal

  • Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

    Jürgen Floege;Joseph Kim;Elizabeth Ireland;Charles Chazot

  • Effects of Phosphate Binders in Moderate CKD

    Geoffrey A. Block;David C. Wheeler;Martha S. Persky;Bryan Kestenbaum

  • Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials

    R Clarke;C Frost;P Sherliker;S Lewington

  • EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-γ–dependent mechanism

    Hang Li;Xiong Z. Ruan;Xiong Z. Ruan;Stephen H. Powis;Stephen H. Powis;Ray Fernando;Ray Fernando

  • Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Arlene B. Chapman;Olivier Devuyst;Kai-Uwe Eckardt;Ron T. Gansevoort

  • Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.

    Mark J. Sarnak;Kerstin Amann;Sripal Bangalore;João L. Cavalcante

  • Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease

    Gavin J. Becker;David C. Wheeler;Dick De Zeeuw;Toshiro Fujita

  • Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial

    Jicheng Lv;Jicheng Lv;Hong Zhang;Muh Geot Wong;Meg J. Jardine

Frequent Co-Authors

Hiddo J.L. Heerspink
Hiddo J.L. Heerspink University of Groningen
Adeera Levin
Adeera Levin University of British Columbia
Allison Tong
Allison Tong University of Sydney
Vlado Perkovic
Vlado Perkovic George Institute for Global Health
Jonathan C. Craig
Jonathan C. Craig Flinders University
Wolfgang C. Winkelmayer
Wolfgang C. Winkelmayer Baylor College of Medicine
Colin Baigent
Colin Baigent University of Oxford
Carol A. Pollock
Carol A. Pollock University of Sydney
Bruce Neal
Bruce Neal George Institute for Global Health
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens the door to many related fields and advanced degrees that can be taken online. For those interested in leadership and management, a master's in healthcare administration online offers flexibility and prepares graduates to manage hospitals and other healthcare institutions.

Aspiring nurses aiming for higher credentials can consider the cheapest dnp program options, which provide an affordable path to earning a Doctor of Nursing Practice degree from anywhere in the country.

For students who want to become pharmacists, exploring pharmacy school online accredited programs can be a practical option that ensures quality education and professional licensure readiness.

Finally, technology-focused students can choose a health information management degree online to launch a career at the intersection of healthcare and data.

These online programs provide flexible learning opportunities and diverse career pathways for anyone looking to make an impact in healthcare beyond traditional medical practice.

Best Scientists Citing David C. Wheeler

Trending Scientists